Earnings & Reporting

The Canadian retailer's Q3 results show strong sales growth, but a sharp drop in net earnings reveals the high price of its ambitious turnaround plan.

European FinTech Multitude AG unveils its 2026 financial calendar, offering investors a clear roadmap amid strong growth and evolving market dynamics.

Formerly a green housing developer, the company is now RenX Enterprises, betting its future on the multi-billion dollar market for sustainable soils.

SCWorx Corp. has signed a new agreement with a 500-bed academic hospital, highlighting the critical need for clean data in complex Workday ERP systems.

How ONAR Holding's newly acquired agency, JUICE, used AI to shatter holiday sales records, validating a high-stakes M&A strategy for investors.

A new poll shows most Canadians are staying home for the holidays, citing costs. But for those who travel, local adventures are the new luxury.

The famed travel host joins the Day1 program to discuss how global exploration can be a profound spiritual practice, fostering hope in a divided world.

As gold, silver, and platinum hit historic highs, Deutsche Bank is issuing new securities for its physically-backed Xtrackers products to meet demand.

Amid rising food insecurity, US Foods delivered nearly $12.5M in aid, powered by a 70% surge in employee volunteerism and new strategic programs.

The iGaming supplier launches 80 exclusive games in Brazil's new regulated market, a strategic move to capture growth in Latin America's largest economy.

Fairholme's year-end dividends are more than just income. We dissect the funds' high-risk, non-diversified strategy and what it means for investors.

Amid a major corporate overhaul, Emergent BioSolutions secures a key FDA approval, signaling a new era for the firm and for U.S. biodefense strategy.

As Uxin prepares to report Q3 results, all eyes are on its ambitious superstore strategy and whether it can drive profitability in a complex market.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

A new startup is betting a premium AI desktop calendar can cure our smartphone addiction. But is another screen really the answer to too much screen time?

A hedge fund's disclosure reveals a puzzling short position and a fresh stock purchase in American Axle, hinting at a high-stakes arbitrage play.

Polyrizon's novel hydrogel shows it can stick to nasal tissue longer without slowing drug delivery, a key innovation in the fight against opioid overdose.

Stewart Information Services is raising millions via a stock offering. We analyze the strategy, the market signals, and the impact on shareholder value.

Borr Drilling leverages complex debt and equity financing to acquire five premium rigs, a high-stakes bet on a strengthening offshore drilling market.

With a new $2B share buyback and strong dividends, Royal Caribbean isn't just recovering; it's setting a new course for shareholder value and growth.